Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer by Sharma, Priyanka, Abramson, Vandana G, O'Dea, Anne, Nye, Lauren, Mayer, Ingrid, Pathak, Harsh B, Hoffmann, Marc, Stecklein, Shane R, Elia, Manana, Lewis, Sharon, Scott, Jecinta, De Jong, Jilliann A, Wang, Yen Y, Yoder, Rachel, Schwensen, Kelsey, Finke, Karissa, Heldstab, Jaimie, LaFaver, Stephanie, Williamson, Stephen K, Phadnis, Milind A, Reed, Gregory A, Kimler, Bruce F, Khan, Qamar J, Godwin, Andrew K

Get full text